Stockscreener 앱 받기
1.26
3.08%
-0.04
전일 마감가:
$1.30
열려 있는:
$1.28
하루 거래량:
32,919
Relative Volume:
0.06
시가총액:
$5.17M
수익:
$502.40K
순이익/손실:
$-7.91M
주가수익비율:
-0.1264
EPS:
-9.972
순현금흐름:
$-4.32M
1주 성능:
-4.55%
1개월 성능:
-5.26%
6개월 성능:
-44.00%
1년 성능:
-86.88%
1일 변동 폭
$1.26
$1.2892
1주일 범위
$1.26
$1.35
52주 변동 폭
$1.24
$12.70
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
명칭
60 Degrees Pharmaceuticals Inc
전화
202-327-5422
주소
1025 CONNECTICUT AVENUE NW, WASHINGTON
SXTP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.26 | 4.19M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스
Using Ichimoku Cloud for 60 Degrees Pharmaceuticals Inc. Equity Warrant technicals2025 Winners & Losers & High Accuracy Trade Alerts - Newser
How to forecast 60 Degrees Pharmaceuticals Inc. Equity Warrant trends using time seriesWeekly Trend Report & Entry and Exit Point Strategies - Newser
Key metrics from 60 Degrees Pharmaceuticals Inc. Equity Warrant’s quarterly dataGold Moves & Short-Term Swing Trade Alerts - Newser
Can swing trading help recover from 60 Degrees Pharmaceuticals Inc. lossesJuly 2025 Market Mood & Pattern Based Trade Signal System - Newser
Quantitative breakdown of 60 Degrees Pharmaceuticals Inc. Equity Warrant recent moveQuarterly Earnings Summary & Reliable Momentum Entry Alerts - Newser
Has 60 Degrees Pharmaceuticals Inc. found a price floorWeekly Market Report & Reliable Price Breakout Alerts - Newser
Using Bollinger Bands to evaluate 60 Degrees Pharmaceuticals Inc. Equity WarrantTrade Risk Report & Growth Oriented Trade Recommendations - Newser
Earnings visualization tools for 60 Degrees Pharmaceuticals Inc.2025 Historical Comparison & Weekly Setup with High ROI Potential - Newser
Custom strategy builders for tracking 60 Degrees Pharmaceuticals Inc.2025 Technical Patterns & AI Driven Price Predictions - Newser
How to recover losses in 60 Degrees Pharmaceuticals Inc. Equity Warrant stockAnalyst Downgrade & Risk Managed Investment Signals - Newser
60 Degrees Pharmaceuticals Inc. Equity Warrant stock trendline breakdownQuarterly Performance Summary & Accurate Technical Buy Alerts - Newser
Measuring 60 Degrees Pharmaceuticals Inc. Equity Warrant’s beta against major indicesM&A Rumor & Long-Term Safe Return Strategies - Newser
Analyzing net buyer seller activity in 60 Degrees Pharmaceuticals Inc.Wall Street Watch & Weekly Top Gainers Trade List - Newser
60 Degrees Pharmaceuticals Inc. stock retracement – recovery analysisQuarterly Growth Report & Capital Efficient Trade Techniques - Newser
Should you hold or exit 60 Degrees Pharmaceuticals Inc. nowGold Moves & Free AI Powered Buy and Sell Recommendations - Newser
Should you wait for a breakout in 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Technical Patterns & Growth Focused Stock Pick Reports - Newser
60 Degrees Pharma to begin trial of tafenoquine for chronic babesiosis - Investing.com
First Potential Treatment for Chronic Babesiosis: 60 Degrees Pharma Launches Key Phase 2 Trial at Mount Sinai - Stock Titan
What’s the recovery path for long term holders of 60 Degrees Pharmaceuticals Inc.Market Movers & Low Drawdown Momentum Ideas - Newser
Real time breakdown of 60 Degrees Pharmaceuticals Inc. stock performanceJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - Newser
Does 60 Degrees Pharmaceuticals Inc. qualify in momentum factor screeningJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - Newser
Is This the Dip to Buy in 60 Degrees Pharmaceuticals Inc.Weekly Trade Review & AI Powered Buy/Sell Recommendations - newsyoung.net
Strategies to average down on 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant rally from current levelsWeekly Earnings Recap & Accurate Intraday Trading Signals - Newser
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock ready for a breakoutPortfolio Return Report & Fast Gain Swing Trade Alerts - Newser
60 Degrees Pharmaceuticals Reports Q2 2025 Earnings - MSN
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant Escape Recent Bear Channel2025 Market Outlook & AI Enhanced Trade Execution Alerts - newsyoung.net
60 Degrees Pharmaceuticals: Navigating Liquidity Risks and High-Stakes Clinical Potential in a Small-Cap Biotech Play - AInvest
60 Degrees Pharmaceuticals Second Quarter 2025 Earnings: Revenues Disappoint - Yahoo Finance
60 Degrees Pharmaceuticals Inc. Pullback Analyzed — Is It Time to Exit2025 Analyst Calls & Weekly Market Pulse Updates - beatles.ru
Using flow based indicators on 60 Degrees Pharmaceuticals Inc.Gap Up & Risk Controlled Stock Alerts - Newser
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant recover in the next quarterWeekly Trade Analysis & High Accuracy Swing Entry Alerts - Newser
Analyzing 60 Degrees Pharmaceuticals Inc. with risk reward ratio chartsJuly 2025 Opening Moves & Advanced Technical Signal Analysis - Newser
Can you recover from losses in 60 Degrees Pharmaceuticals Inc.2025 Market Sentiment & AI Forecast Swing Trade Picks - Newser
Is a relief rally coming for 60 Degrees Pharmaceuticals Inc. Equity Warrant holdersEarnings Overview Report & Safe Entry Point Identification - Newser
Reversal indicators forming on 60 Degrees Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Intraday Action & Fast Gain Stock Tips - Newser
Using fundamentals and technicals on 60 Degrees Pharmaceuticals Inc.Trade Signal Summary & Daily Momentum Trading Reports - Newser
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant a candidate for recovery playVolume Spike & Proven Capital Preservation Methods - Newser
Published on: 2025-08-17 15:22:54 - Newser
What technical models suggest about 60 Degrees Pharmaceuticals Inc.’s comebackWeekly Trend Summary & Low Risk High Win Rate Stock Picks - Newser
Published on: 2025-08-13 00:13:33 - Newser
What moving averages say about 60 Degrees Pharmaceuticals Inc. Equity WarrantWatch List & Stepwise Entry and Exit Trade Signals - Newser
Can trapped investors hope for a rebound in 60 Degrees Pharmaceuticals Inc.2025 Trade Ideas & Fast Exit and Entry Trade Guides - Newser
How sentiment analysis helps forecast 60 Degrees Pharmaceuticals Inc.Portfolio Profit Report & Verified Swing Trading Watchlists - Newser
Using economic indicators to assess 60 Degrees Pharmaceuticals Inc. potentialQuarterly Earnings Summary & High Yield Stock Recommendations - Newser
What to do if you’re stuck in 60 Degrees Pharmaceuticals Inc. Equity WarrantLayoff News & Free Technical Confirmation Trade Alerts - Newser
Using fundamentals and technicals on 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Drop Watch & Free Community Supported Trade Ideas - Newser
What momentum shifts mean for 60 Degrees Pharmaceuticals Inc. Equity WarrantPortfolio Risk Summary & Fast Moving Trade Plans - Newser
60 Degrees Pharmaceuticals Inc. stock daily chart insights2025 Volatility Report & Proven Capital Preservation Tips - Newser
60 Degrees Pharmaceuticals Inc (SXTP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
60 Degrees Pharmaceuticals Inc 주식 (SXTP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
| XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
0.94%
1.72%
자본화:
|
볼륨(24시간):